Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Crescent Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.

Get CBIO alerts

About Ellie

Ellie has spoken on 1 investor event across 1 company, most recently for Crescent Biopharma, Inc. on November 10, 2026. Crescent Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Crescent Biopharma, Inc. includes Harout Semerjian (CEO and Board Member), Joshua Brumm (CEO and Board Member), Peter Harwin (Chairman and Board Member) and 7 others.

Ellie on recent calls

“In our global phase 1-2 study called ASCEND, we have started dosing patients in February of this year, And then we are enrolling patients from the United States, Europe, and South Korea.”
Other, Stifel 2026 Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Crescent Biopharma, Inc.

Recent activity